Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Protalix BioTherapeutics, Inc. | y04571e10vk.htm |
| EX-32.2 - EX-32.2 - Protalix BioTherapeutics, Inc. | y04571exv32w2.htm |
| EX-31.2 - EX-31.2 - Protalix BioTherapeutics, Inc. | y04571exv31w2.htm |
| EX-32.1 - EX-32.1 - Protalix BioTherapeutics, Inc. | y04571exv32w1.htm |
| EX-31.1 - EX-31.1 - Protalix BioTherapeutics, Inc. | y04571exv31w1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No.
333-171615) and Registration Statement on Form S-8 (No. 333-148983) of Protalix BioTherapeutics,
Inc. of our report dated February 23, 2011 relating to the financial statements and the
effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ Kesselman & Kesselman
Kesselman & Kesselman
Certified Public Accountants (lsr.)
A member firm of PricewaterhouseCoopers International Limited
Certified Public Accountants (lsr.)
A member firm of PricewaterhouseCoopers International Limited
Tel-Aviv, Israel
February 23, 2011
February 23, 2011
Kesselman
& Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 68125, Israel, P.O. Box
452 Tel-Aviv 61003 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.co.il